keyword
https://read.qxmd.com/read/38618352/medical-students-preferences-of-study-resources-physical-vs-digital-resources
#1
JOURNAL ARTICLE
Marwah Al Shmanee, Moaaz Issa, Hind Alkholy, Amna Alnaqbi, Abdalrhman Awadallah, Hadil Hassan, Amal Hussein
Introduction Medical school students are presently confronted with distinct study resources, that can be categorized into physical and digital formats. Additionally, existing literature offers limited insights into the most efficacious and favored modalities of study adopted by medical students. The following research seeks to elucidate the optimum mode of study embraced by medical students, concurrently examining the determinants influencing their choices. Methods A cross-sectional study was conducted, encompassing a cohort of 572 students from the Colleges of Medicine and Dental Medicine at the University of Sharjah, Sharjah, UAE...
March 2024: Curēus
https://read.qxmd.com/read/38558740/development-of-the-emirates-multi-criteria-decision-analysis-tool-for-orphan-drugs
#2
JOURNAL ARTICLE
Khalid A Alnaqbi, Baher Elezbawy, Ahmad N Fasseeh, Abdul Rauf Bangash, Amin Elshamy, Hiba Shendi, Mohammed I Aftab, Mozah AlMarshoodi, Nicole Gebran, Noura AlDhaheri, Sahar A Fahmy, Sara Al Dallal, Waeil Al Naeem, Sherif Abaza, Zoltán Kaló
Background The number of orphan drug approvals is currently increasing globally. This creates a significant burden on payers and healthcare systems. This study aimed to create a multi-criteria decision analysis (MCDA) tool for evaluating orphan drugs within the United Arab Emirates (UAE). The intended result of the tool is to provide evidence-based guidance to decision-makers in reimbursement and procurement decisions. Methods We conducted a literature search and local expert interviews to identify relevant preliminary criteria for the MCDA tool...
February 2024: Curēus
https://read.qxmd.com/read/38533505/ozanimod-mediated-remission-in-experimental-autoimmune-encephalomyelitis-is-associated-with-enhanced-activity-of-cns-cd27-low-nk-cell-subset
#3
JOURNAL ARTICLE
Doua Kamyan, Maya Hassane, Alanood Alnaqbi, Abdul-Kader Souid, Zakeya Al Rasbi, Abeer Al Tahrawi, Mariam Al Shamsi
BACKGROUND: Ozanimod (RPC1063) is an immunomodulator that has been recently approved by the FDA (2020) for the treatment of relapsing-remitting multiple sclerosis (RRMS). It is a selective agonist of the sphingosine-1-phophate receptors 1 and 5, expressed on naïve and central memory T and B cells, as well as natural killer (NK) cells, and is involved in lymphocyte trafficking. Oral administration of ozanimod was reported to result in rapid and reversible reduction in circulating lymphocytes in multiple sclerosis (MS) patients, however, only minimal effect on NK cells was observed...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38402494/consensus-based-overarching-principles-and-recommendations-on-the-use-of-biosimilars-in-the-treatment-of-inflammatory-arthritis-in-the-gulf-region
#4
JOURNAL ARTICLE
Khalid A Alnaqbi, Nasra Al Adhoubi, Sara Aldallal, Samar Al Emadi, Adeeba Al-Herz, Amin M El Shamy, Suad Hannawi, Mohammed A Omair, Sahar A Saad, Tore K Kvien
BACKGROUND: Though biologic agents have significantly improved the treatment of inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis), high costs, stringent regulations, strict reimbursement criteria, and existing patents have limited patient access to treatments. While being highly similar in quality, safety, and efficacy to biologic reference products, biosimilars can reduce the financial burden and prevent underutilization of medication. OBJECTIVE: The objective of this initiative was to develop an evidence-based consensus of overarching principles and recommendations aimed at standardizing the use of biosimilars in treating inflammatory arthritis in the Gulf region...
February 25, 2024: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/38353792/a-rare-twist-covid-19-infection-masquerading-as-iga-vasculitis-in-a-hemophilia-a-patient
#5
REVIEW
Khalid A Alnaqbi, Nasser Abunamous, Tausif Saleem
Hemophilia A and B are one of the most common hereditary bleeding disorders. Patients are predisposed to bleeding spontaneously or after minor trauma in different areas such as the skin, gastrointestinal, or joints. COVID-19 infection has been associated with various clinical manifestations and complications including rarely triggering IgA vasculitis. We report a 23-year-old man who was previously diagnosed with severe hereditary hemophilia A. He presented to our hospital with classic symptoms of IgA vasculitis, complaining of petechiae and purpura in his limbs, fatigue, body aches, poor oral intake, abdominal pain, and watery non-bloody diarrhea...
February 14, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38337023/investigating-the-genetic-makeup-of-the-major-histocompatibility-complex-mhc-in-the-united-arab-emirates-population-through-next-generation-sequencing
#6
JOURNAL ARTICLE
Nour Al Dain Marzouka, Halima Alnaqbi, Amira Al-Aamri, Guan Tay, Habiba Alsafar
The Human leukocyte antigen (HLA) molecules are central to immune response and have associations with the phenotypes of various diseases and induced drug toxicity. Further, the role of HLA molecules in presenting antigens significantly affects the transplantation outcome. The objective of this study was to examine the extent of the diversity of HLA alleles in the population of the United Arab Emirates (UAE) using Next-Generation Sequencing methodologies and encompassing a larger cohort of individuals. A cohort of 570 unrelated healthy citizens of the UAE volunteered to provide samples for Whole Genome Sequencing and Whole Exome Sequencing...
February 9, 2024: Scientific Reports
https://read.qxmd.com/read/38314378/long-lasting-complete-remission-in-a-patient-with-metastatic-metaplastic-breast-cancer-treated-with-immune-checkpoint-inhibitor-and-chemotherapy-a-case-report-and-a-review-of-the-literature
#7
Aydah Al-Awadhi, Safia Alnaqbi, Alia Albawardi
Metaplastic breast cancer (MpBC) is a rare form of breast cancer known for suboptimal response to chemotherapy, high recurrence rate, poor prognosis, and limited treatment options. Recent studies have reported that MpBC has high expression of programmed death ligand 1 and tumor-infiltrating lymphocytes, indicating the potential effectiveness of immunotherapy (IO) in MpBC. In addition, several reports have demonstrated the activity of IO in MpBC. In this case report, we present a case of recurrent MpBC that achieved durable, rapid, complete remission with atezolizumab (anti-PD-L1) and nab-paclitaxel with a continued response even after discontinued therapy...
February 2024: Curēus
https://read.qxmd.com/read/38130907/correction-cardiac-arrhythmia-and-heart-failure-shortly-after-starting-romosozumab-for-osteoporosis-a-case-based-review
#8
Khalid A Alnaqbi, Jawaher Al Zeyoudi, Asma K Aljaberi
[This corrects the article DOI: 10.7759/cureus.50303.].
December 2023: Curēus
https://read.qxmd.com/read/38111814/paradoxical-psoriasis-and-worsening-spondylitis-due-to-secukinumab-in-a-patient-with-ankylosing-spondylitis-a-case-report-and-literature-review
#9
Khalid A Alnaqbi, Jawaher Al Zeyoudi, Fahad Fazal, Omar M Alhaj, Imad Jassim, Fatima A Albreiki
Axial spondyloarthritis (axSpA) is an autoimmune disease primarily affecting the axial skeleton, with associated extra-musculoskeletal manifestations. Treatment strategies targeting cytokines tumor necrosis factor-alpha (TNF-α) and interleukin 17 (IL-17) have proven effective. However, paradoxical reactions, including paradoxical psoriasis and arthritis, have been reported in axSpA patients receiving TNF-α inhibitors. IL-17 inhibitors have been used as an alternative treatment option, but paradoxical reactions have also been rarely observed...
December 2023: Curēus
https://read.qxmd.com/read/38089947/cardiac-arrhythmia-and-heart-failure-shortly-after-starting-romosozumab-for-osteoporosis-a-case-based-review
#10
Khalid A Alnaqbi, Jawaher Al Zeyoudi, Asma K Aljaberi
Romosozumab is a humanized monoclonal antibody that targets the sclerostin protein, which regulates bone formation and resorption. It is a novel therapy in the treatment of post-menopausal women with osteoporosis. The evidence regarding romosozumab's cardiovascular safety is conflicting. We report the first post-marketing case demonstrating cardiac events (i.e., atrial fibrillation and congestive heart failure) in a female patient with osteoporosis likely triggered by romosozumab. A literature review on romosozumab and cardiovascular disease is discussed extensively...
December 2023: Curēus
https://read.qxmd.com/read/37993860/telemedicine-perception-and-interest-among-medical-students-at-the-university-of-sharjah-united-arab-emirates-2023
#11
JOURNAL ARTICLE
Abdulaziz H Albahri, Shatha A Alnaqbi, Shahad A Alnaqbi, Sarra Shorbagi
BACKGROUND: Telemedicine is becoming an integral part of healthcare. Training medical students in telemedicine is encouraged by many medical organizations. However, in the United Arab Emirates in particular, most medical schools have not incorporated it into their curriculum. Therefore, this study aims to assess medical students' perceptions and interest in telemedicine teaching at the University of Sharjah, UAE. METHODS: A questionnaire-based survey was built based on the current literature and was distributed to all medical students at the University of Sharjah between February and March 2023...
November 22, 2023: BMC Medical Education
https://read.qxmd.com/read/37824571/experiences-of-university-teachers-with-rotational-blended-learning-during-the-covid-19-pandemic-a-qualitative-case-study
#12
JOURNAL ARTICLE
Ahmed Alkaabi, Ahmad Qablan, Fatima Alkatheeri, Aisha Alnaqbi, Maha Alawlaki, Latifa Alameri, Bushra Malhem
This qualitative case study examines the self-efficacy of university teachers during the COVID-19 pandemic as they struggle to incorporate new technology, teaching strategies, and curriculum delivery in the shift from total remote learning to biweekly rotation learning--two weeks of face-to-face learning and two weeks online. This study was conducted over one full semester among university teachers teaching undergraduate students with the rotation model at one federal university located in the United Arab Emirates...
2023: PloS One
https://read.qxmd.com/read/37736239/shaping-the-future-the-transformative-path-of-the-arab-board-of-rheumatology
#13
EDITORIAL
Khalid A Alnaqbi, Salwa A Al Cheikh
Rheumatology fellowship programs represent a pivotal juncture for aspiring specialists, embarking on a transformative journey of expertise and care. The League of Arab States, comprising 22 nations and a collective population of 464.68 million as of 2022, established the Arab Board of Health Specialization in February 1978. This visionary initiative aimed to curb the emigration of Arab physicians and address the scarcity of specialized medical practitioners in the Arab world. Since the establishment of the Internal Medicine specialty in 1979, the curriculum and examinations have undergone sustained refinement and enhancement...
September 2023: Curēus
https://read.qxmd.com/read/37708194/hla-class-i-associations-with-the-severity-of-covid-19-disease-in-the-united-arab-emirates
#14
JOURNAL ARTICLE
Guan K Tay, Halima Alnaqbi, Sarah Chehadeh, Braulio Peramo, Farah Mustafa, Tahir A Rizvi, Bassam H Mahboub, Maimunah Uddin, Nawal Alkaabi, Eman Alefishat, Herbert F Jelinek, Habiba Alsafar
SARS-CoV-2 appears to induce diverse innate and adaptive immune responses, resulting in different clinical manifestations of COVID-19. Due to their function in presenting viral peptides and initiating the adaptive immune response, certain Human Leucocyte Antigen (HLA) alleles may influence the susceptibility to severe SARS-CoV-2 infection. In this study, 92 COVID-19 patients from 15 different nationalities, with mild (n = 30), moderate (n = 35), and severe (n = 27) SARS-CoV-2 infection, living in the United Arab Emirates (UAE) were genotyped for the Class I HLA -A, -C, and -B alleles using next-generation sequencing (NGS) between the period of May 2020 to June 2020...
2023: PloS One
https://read.qxmd.com/read/37693908/an-international-comparative-analysis-and-roadmap-to-sustainable-biosimilar-markets
#15
JOURNAL ARTICLE
Khalid A Alnaqbi, Agnès Bellanger, Alex Brill, Gilberto Castañeda-Hernández, Ana Clopés Estela, Olga Delgado Sánchez, Pilar García-Alfonso, Pius Gyger, Daniel Heinrich, Germain Hezard, Adriana Kakehasi, Cheryl Koehn, Olivier Mariotte, Francesco Mennini, Sonia Mayra Pérez-Tapia, Michele Pistollato, Rowan Saada, Tadanori Sasaki, George Tambassis, Marc Thill, Gustavo Werutsky, Tim Wilsdon, Steven Simoens
Background: Although biosimilar uptake has increased (at a variable pace) in many countries, there have been recent concerns about the long-term sustainability of biosimilar markets. The aim of this manuscript is to assess the sustainability of policies across the biosimilar life cycle in selected countries with a view to propose recommendations for supporting biosimilar sustainability. Methods: The study conducted a comparative analysis across 17 countries from North America, South America, Asia-Pacific, Europe and the Gulf Cooperation Council...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37589761/pharmacological-inhibition-of-pten-rescues-dopaminergic-neurons-by-attenuating-apoptotic-and-neuroinflammatory-signaling-events
#16
JOURNAL ARTICLE
Aishwarya Mary Johnson, Sara Jose, Abdul Rasheed Palakkott, Farheen Badrealam Khan, Nanthini Jayabalan, Jaleel Kizhakkayil, Shamma Abdulla Ali AlNaqbi, Mark Gh Scott, Mohammed Akli Ayoub, Richard Gordon, Hariharan Saminathan
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the selective degeneration of dopaminergic neurons in the substantia nigra pars compacta resulting in an irreversible and a debilitating motor dysfunction. Though both genetic and idiopathic factors are implicated in the disease etiology, idiopathic PD comprise the majority of clinical cases and is caused by exposure to environmental toxicants and oxidative stress. Fyn kinase activation has been identified as an early molecular signaling event that primes neuroinflammatory and neurodegenerative events associated with dopaminergic cell death...
August 17, 2023: Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology
https://read.qxmd.com/read/37454085/knowledge-attitudes-and-perceptions-of-the-multi-ethnic-population-of-the-united-arab-emirates-on-genomic-medicine-and-genetic-testing
#17
JOURNAL ARTICLE
Azhar T Rahma, Bassam R Ali, George P Patrinos, Luai A Ahmed, Iffat Elbarazi, Aminu S Abdullahi, Mahanna Elsheik, Maram Abbas, Farah Afandi, Aisha Alnaqbi, Fatma Al Maskari
INTRODUCTION: The adoption and implementation of genomic medicine and pharmacogenomics (PGx) in healthcare systems have been very slow and limited worldwide. Major barriers to knowledge translation into clinical practice lie in the level of literacy of the public of genetics and genomics. The aim of this study was to assess the knowledge, attitudes, and perceptions of the United Arab Emirates (UAE) multi-ethnic communities toward genomic medicine and genetic testing. METHOD: A cross-sectional study using validated questionnaires was distributed to the participants...
July 15, 2023: Human Genomics
https://read.qxmd.com/read/37349410/understanding-tumour-endothelial-cell-heterogeneity-and-function-from-single-cell-omics
#18
REVIEW
Qun Zeng, Mira Mousa, Aisha Shigna Nadukkandy, Lies Franssens, Halima Alnaqbi, Fatima Yousif Alshamsi, Habiba Al Safar, Peter Carmeliet
Anti-angiogenic therapies (AATs) are used to treat different types of cancers. However, their success is limited owing to insufficient efficacy and resistance. Recently, single-cell omics studies of tumour endothelial cells (TECs) have provided new mechanistic insight. Here, we overview the heterogeneity of human TECs of all tumour types studied to date, at the single-cell level. Notably, most human tumour types contain varying numbers but only a small population of angiogenic TECs, the presumed targets of AATs, possibly contributing to the limited efficacy of and resistance to AATs...
August 2023: Nature Reviews. Cancer
https://read.qxmd.com/read/37287950/comprehensive-description-of-the-prevalence-serological-and-clinical-characteristics-and-visceral-involvement-of-systemic-sclerosis-scleroderma-in-a-large-cohort-from-the-united-arab-emirates-systemic-sclerosis-registry
#19
JOURNAL ARTICLE
Rajaie Namas, Mohamed Elarabi, Saniya Khan, Asia Mubashir, Esat Memisoglu, Mahmoud El-Kaissi, Abhay Joshi, Jeffrey Chapman, Imad Jassim, Hiba Khogali, Nada Hassan, Hani Sabbour, Khaled Saleh, Khalid A Alnaqbi, Ahmed S Zayat, Sehriban Diab, Zyiad Awir, Nehad Abu Taha, Amel Ginawi, Atheer Al Ansari, Hazem Rifaai, Zaid Alrawi, Afra Al Dhaheri, Gamal Ibrahim, Ahmed Abogamal, Waleed Al Shehhi, Jamal Teir, Tahir Khan, Maisam Musgrave, Beena Hameed, Bhavna Khan, Nagwa Mosallam, Nahla Hussien, Iman Hussein, Abeer Abdulelhamid, Ahmed Ali, Suad Hannawi, Mustafa Al Izzi, Humeira Badsha, Jamal Al Saleh
Systemic sclerosis is an autoimmune condition characterized by a wide range of clinical presentations. Registries may serve to expand understanding about systemic sclerosis and aid in patient care and follow-up. The objective of this study was to analyze the prevalence of systemic sclerosis in a large cohort from the United Arab Emirates Systemic Sclerosis Registry and find the significant similarities and differences between the different subsets. All scleroderma patients in the United Arab Emirates were included in this multicenter national retrospective analysis...
June 2023: Journal of Scleroderma and related Disorders
https://read.qxmd.com/read/37185751/molecular-heterogeneity-of-the-brain-endothelium
#20
JOURNAL ARTICLE
Nada Alnaqbi, Mohammad G Mohammad, Rifat Hamoudi, Aloïse Mabondzo, Rania Harati
The blood-brain barrier (BBB) is part of a neurovascular structure located in the brain's micro vessels, that is essential to maintain brain homeostasis, but prevents the brain uptake of most drugs. Because of its importance in neuro-pharmacotherapy, the BBB has been the subject of extensive research since its discovery over 100 years ago. Major advances in understanding the structure and function of the barrier have been made. Drugs are re-designed to cross the BBB. However, despite these efforts, overcoming the BBB efficiently to treat brain diseases safely remains challenging...
April 16, 2023: Current Issues in Molecular Biology
keyword
keyword
3334
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.